A. Sidorchuk

发表

M. Wickman, G. Pershagen, F. Lagarde, 2004, The Journal of allergy and clinical immunology.

P. Allebeck, K. McGlynn, O. Akre, 2017, Cancer Epidemiology, Biomarkers & Prevention.

P. Allebeck, R. Callaghan, A. Sidorchuk, 2013, Cancer Causes & Control.

P. Lichtenstein, C. Rück, D. Mataix-Cols, 2020, Journal of psychiatric research.

R. Kuja‐Halkola, D. Mataix-Cols, H. Larsson, 2020, Psychological Medicine.

D. Mataix-Cols, H. Larsson, L. Fernández de la Cruz, 2019, JAMA network open.

D. Mataix-Cols, H. Larsson, L. Fernández de la Cruz, 2021, Movement disorders : official journal of the Movement Disorder Society.

L. Johansson, A. Sidorchuk, G. Ågren, 2019, Drug and alcohol dependence.

C. Rück, D. Mataix-Cols, H. Larsson, 2021, Psychological Medicine.

C. Rück, D. Mataix-Cols, H. Larsson, 2021 .

J. Möller, K. Engström, A. Sidorchuk, 2022, Nordisk alkohol- & narkotikatidskrift : NAT.

P. Allebeck, O. Aremu, E. Agardh, 2009, Cancer Causes & Control.

J. Hallqvist, T. Moradi, A. Sidorchuk, 2010, Scandinavian journal of public health.

P. Allebeck, E. Agardh, J. Hallqvist, 2011, International journal of epidemiology.

J. Hallqvist, T. Moradi, A. Sidorchuk, 2010, Journal of Epidemiology & Community Health.

P. Allebeck, R. Callaghan, A. Sidorchuk, 2013, Cancer Causes & Control.

P. Allebeck, E. Agardh, J. Hallqvist, 2011, Population health metrics.

B. D’Onofrio, R. Kuja‐Halkola, D. Mataix-Cols, 2020, JAMA network open.

M. Wickman, G. Pershagen, F. Lagarde, 2003, The Pediatric infectious disease journal.

R. Kuja‐Halkola, D. Mataix-Cols, H. Larsson, 2021 .

P. Lichtenstein, B. D’Onofrio, D. Mataix-Cols, 2020, Movement disorders : official journal of the Movement Disorder Society.

P. Lichtenstein, R. Kuja‐Halkola, D. Mataix-Cols, 2023, Movement disorders : official journal of the Movement Disorder Society.

D. Mataix-Cols, L. Fernández de la Cruz, J. Isung, 2022, Biological Psychiatry.

L. Johansson, A. Sidorchuk, G. Ågren, 2019, Drug and alcohol dependence.

D. Mataix-Cols, K. Isomura, P. Quinn, 2024, CNS drugs.